Open AccessImpact of drug resistance mutations on virologic response to salvage therapy
Author(s) -
Patrizio Lorenzi,
Milos Opravil,
Bernard Hirschel,
Jean-Philippe Chave,
H. Furrer,
Hugo Sax,
Thomas Perneger,
Luc Perrin,
Laurent Kaiser,
Sabine Yerly
Publication year - 1999
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199902040-00001
Subject(s) - salvage therapy , protease inhibitor (pharmacology) , medicine , drug resistance , protease , nelfinavir , viral load , reverse transcriptase , gastroenterology , virology , oncology , biology , immunology , chemotherapy , virus , antiretroviral therapy , rna , gene , enzyme , biochemistry , microbiology and biotechnology
To assess the prognostic significance of drug-associated mutations in the protease and reverse transcriptase (RT) genes on virological response to salvage therapy.